Full Text
Cost-Effectiveness Of First-Line Therapy For Advanced Non-Small Cell Lung Cancer (Nsclc)

Abstract

Authors

MC Yang ECH Tan

Back to Volume 17, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×